The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Qatar to host Intercontinental Cup finals
- Sudan clears imports of more Brazilian products
- Event highlights opportunities in the Arab world
- Dubai in wood: The art of Francisco Suelo
- Passenger numbers rise on flights in Brazil
- Brazil adds USD 1.29 billion to export credit
- Saudi bank launches export accelerator
- Brazil tackles Newcastle disease in southern state
